Our findings demonstrate that ASF1B is significantly overexpressed in breast cancer tissues compared to normal controls, and that its elevated expression is associated with poor prognosis, aggressive molecular features, and altered immune cell infiltration. Here, ASF1B is linked to breast carcinoma.